Japan (JP)

Multimodal optical coherence tomography, Raman spectroscopy and IR fundus imaging for in vivo retinal imaging (2022) Sentosa R, Stiebing C, Eibel M, Salas M, Jong WD, Jolan-Jahn I, Schmitt M, et al. Conference contribution Absolute Carrier-Envelope-Phase Dependence of Dissociative Ionization of Acetonitrile by Few-Cycle Intense Laser Pulses (2022) Yoshii M, Matsubara T, Ando T, Iwasaki A, Rathje T, Paulus GG, Yamanouchi K Conference contribution Post-Ionization Interaction of OCS in Phase-Locked Two-Color Laser Fields (2022) Endo T, Ziems KM, Richter M, Froebel FG, Hishikawa A, Gräfe S, Légaré F, Ibrahim H Conference contribution A differential of the left eye and right eye neurological pupil index is associated with discharge modified Rankin scores in neurologically injured patients. (2022) Privitera CM, Neerukonda SV, Aiyagari V, Yokobori S, Puccio AM, Schneider NJ, Stutzman SE, Olson DM Journal article Alteplase for Stroke With Unknown Onset Time in Chronic Kidney Disease: A Pooled Analysis of Individual Participant Data. (2022) Miwa K, Koga M, Jensen M, Inoue M, Yoshimura S, Fukuda-Doi M, Boutitie F, et al. Journal article A NEW POINT OF VIEW ON SKIN-FRICTION CONTRIBUTIONS IN ADVERSE-PRESSURE-GRADIENT TURBULENT BOUNDARY LAYERS (2022) Atzori M, Stroh A, Gatti D, Fukagata K, Vinuesa R, Schlatter P Conference contribution Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. (2022) Kerick M, Acosta-Herrera M, Pilar Simeon-Aznar C, Luis Callejas J, Assassi S, Proudman SM, Nikpour M, et al. Journal article Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever (2022) Kohl L, Siddique MNAA, Bodendorfer B, Berger R, Preikschat A, Daniel C, Ölke M, et al. Journal article Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. (2022) Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, Bauer JM, et al. Journal article Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article